Table 1A. Baseline characteristics and distribution of CVD risk factors across RLP-C quartiles.
| Characteristic | RLP-C Quartiles | P trend | |||
|---|---|---|---|---|---|
| Q1 (0.4–3.1) | Q2 (3.2–5.9) | Q3 (6.0–12.2) | Q4 (12.3–259.1) | ||
| Age (years) | 62.7 ± 5.8 | 62.6 ± 5.7 | 62.8 ± 5.6 | 62.8 ± 5.6 | 0.275 |
| Female (%) | 63.6 | 62.7 | 57.2 | 53.2 | <0.001 |
| African American (%) | 34.3 | 25.0 | 16.6 | 11.0 | <0.001 |
| BMI (kg/m2) | 27.5 ± 6.0 | 28.7 ± 5.8 | 29.3 ± 5.6 | 29.6 ± 4.9 | <0.001 |
| SBP (mmHg) | 125.9 ± 19.8 | 126.8 ± 19.1 | 127.5 ± 18.3 | 128.9 ± 18.2 | <0.001 |
| Hypertension (%) | 42.0 | 44.2 | 46.3 | 50.5 | <0.001 |
| Hypertensive medication user (%) | 36.4 | 40.4 | 41.6 | 45.5 | <0.001 |
| Diabetes (%) | 10.6 | 13.4 | 15.8 | 22.1 | <0.001 |
| Current smoking (%) | 15.6 | 14.7 | 14.2 | 12.5 | 0.002 |
| HDL-C (mg/dL) | 59.7 ± 17.0 | 54.0 ± 16.7 | 48.2 ± 14.5 | 41.2 ± 12.3 | <0.001 |
| LDL-C (mg/dL) | 115.5 ± 30.8 | 124.8 ± 32.7 | 126.6 ± 32.7 | 124.9 ± 35.9 | <0.001 |
| Total cholesterol (mg/dL) | 190.6 ± 32.5 | 200.6 ± 35.0 | 203.8 ± 34.9 | 211.9 ± 40.8 | <0.001 |
| Triglycerides (mg/dL) | 74 (61, 90) | 107 (91, 125) | 141 (119, 167) | 216 (176, 275) | <0.001 |
| Fasting glucose (mg/dL) | 102.3 ± 24.9 | 104.9 ± 25.3 | 107.6 ± 30.1 | 114.6 ± 38.8 | <0.001 |
| Statin user (%) | 6.2 | 8.9 | 9.9 | 12.8 | <0.001 |
| Cholesterol lowering medication user (%) | 7.9 | 10.7 | 12.7 | 17.5 | <0.001 |
| WBC | 5.7 (4.9, 6.9) | 5.9 (5.0, 7.2) | 6.3 (5.3, 7.4) | 6.4 (5.5, 7.6) | <0.001 |
| hs-CRP (mg/L) | 1.94 (0.87, 5.11) | 2.32 (1.04, 5.44) | 2.63 (1.20, 5.50) | 2.78 (1.29, 5.67) | <0.001 |
Data presented as means ± SD, median (25th percentile, 75th percentile), or percentages.